Eliminate culturing to liberate researchers from tedious manual tasks, condense workflows, and increase walk-away time

Organoids are powerful and predictive cell models. Yet the combination of complex culturing protocols and the time needed to acquire organoids ready for use require specialized expertise. These intricacies can extend research timelines considerably—particularly for new or inexperienced users. They also require scientists to spend valuable time on tedious, manual organoid culture work, often hindering adoption.

Even if these hurdles are overcome, it is challenging for scientists to create the consistent organoids required for trustworthy research results. Minor variations in operator technique and culture media composition, for example, can lead to extensive variability between organoid batches, adversely affecting experiment reproducibility and data reliability.

3D Ready Organoids eliminate these obstacles, offering a key to unlocking deeper, more reliable insights.

Danaher Corporation

Danaher Corporation

3D Ready™ Organoids are ready when you are.

These ready-to-use consumables can be conveniently stored in a lab's freezer until you need them. By eliminating the time-consuming task of organoid culture, you can optimize your lab efficiency and dedicate more time to your research, while being confident in your organoid quality. Our solution streamlines your workflow, empowering you to focus on your scientific investigations and accelerate your discoveries while getting your weekends back.

Developed using patent-pending bioprocess technology

Manufactured using our proprietary bioprocess technology, these cryopreserved vials come with full protocols, comprehensive scientific support, and an integrated HUB Organoids license for approved proof-of-concept studies.

Our advanced industrial bioprocess allows us to produce large quantities of organoids with unparalleled quality. Each batch undergoes a rigorous quality assurance process, adhering to our stringent standards. We guarantee uniformity within and between batches, ensuring reproducibility and standardization.

These well-characterized, highly reproducible organoids enable researchers to test new therapeutics, predict patient responses in early-stage drug discovery, and achieve reliable outcomes quickly and easily, all with low upfront investment in time and resources.

3D Ready Organoids

Danaher Corporation

Manual cell culture

Danaher Corporation

Danaher Corporation

Actin filaments in colorectal cancer PDO stained with phalloidin, visualized using the ImageXpress® HCS.ai High-Content Screening System equipped with a deep tissue spinning disk to enhance the signal-to-noise ratio in thick samples.

Resources

Molecular Devices

Patient-derived 3D Ready Organoids for high throughput screening

Poster

Download

Speak to one of our world-leading life sciences experts

id
TTAE
name
TTAE
_clientID
546006278
_deExternalKey
TTAE
_action
add
_returnXML
1
Inquiry_Type
Talk to an Expert
_successURL
https://stage.lifesciences.danaher.com/us/en/solutions/mabs/cell-line-development.html
_errorURL
https://help.salesforce.com/s/articleView?id=sf.mc\_es\_demanager.htm